Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Battezzati

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|December 1, 1991
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationA Crosignani, M Podda, P M Battezzati, et al.
Journal of Hepatology|May 1, 1995
Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulationsG Torgano, M Vecchi, M Podda, et al.
Digestive Diseases and Sciences|April 1, 1996
Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response studyA Crosignani, P M Battezzati, K D Setchell, et al.
Digestive Diseases and Sciences|December 1, 1989
Effect of different doses of ursodeoxycholic acid in chronic liver diseaseM Podda, C Ghezzi, P M Battezzati, et al.
Gut|July 16, 2002
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosisM Longo, A Crosignani, P M Battezzati, et al.
Scandinavian Journal of Gastroenterology|March 1, 1991
Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstonesM Zuin, M L Petroni, G Grandinetti, et al.
Archives of Virology. Supplementum|January 1, 1992
Antibodies to hepatitis C virus in primary biliary cirrhosisE Bertolini, F Marelli, P Zermiani, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosisP Invernizzi, K D Setchell, A Crosignani, et al.
Journal of Hepatology|November 7, 1999
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver diseaseC Colombo, A Crosignani, P M Battezzati, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patientsP M Battezzati, M Zuin, A Crosignani, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|December 1, 1991
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationA Crosignani, M Podda, P M Battezzati, et al.
Journal of Hepatology|May 1, 1995
Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulationsG Torgano, M Vecchi, M Podda, et al.
Digestive Diseases and Sciences|April 1, 1996
Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response studyA Crosignani, P M Battezzati, K D Setchell, et al.
Digestive Diseases and Sciences|December 1, 1989
Effect of different doses of ursodeoxycholic acid in chronic liver diseaseM Podda, C Ghezzi, P M Battezzati, et al.
Gut|July 16, 2002
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosisM Longo, A Crosignani, P M Battezzati, et al.
Scandinavian Journal of Gastroenterology|March 1, 1991
Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstonesM Zuin, M L Petroni, G Grandinetti, et al.
Archives of Virology. Supplementum|January 1, 1992
Antibodies to hepatitis C virus in primary biliary cirrhosisE Bertolini, F Marelli, P Zermiani, et al.
Hepatology (Baltimore, Md.)|January 27, 1999
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosisP Invernizzi, K D Setchell, A Crosignani, et al.
Journal of Hepatology|November 7, 1999
Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver diseaseC Colombo, A Crosignani, P M Battezzati, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patientsP M Battezzati, M Zuin, A Crosignani, et al.
Pageof 5